MGO One Seven’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
16,512
-2,410
| -13% | -$92.5K | 0.02% | 637 |
|
|
2025
Q1 | $733K | Buy |
18,922
+5,486
| +41% | +$213K | 0.03% | 520 |
|
|
2024
Q4 | $454K | Buy |
13,436
+1,997
| +17% | +$67.5K | 0.02% | 646 |
|
|
2024
Q3 | $468K | Sell |
11,439
-1,140
| -9% | -$46.6K | 0.02% | 603 |
|
|
2024
Q2 | $484K | Sell |
12,579
-632
| -5% | -$24.3K | 0.02% | 568 |
|
|
2024
Q1 | $566K | Sell |
13,211
-2,536
| -16% | -$109K | 0.03% | 485 |
|
|
2023
Q4 | $584K | Sell |
15,747
-2,623
| -14% | -$97.2K | 0.03% | 461 |
|
|
2023
Q3 | $666K | Buy |
18,370
+10,536
| +134% | +$382K | 0.05% | 350 |
|
|
2023
Q2 | $279K | Sell |
7,834
-478
| -6% | -$17K | 0.03% | 622 |
|
|
2023
Q1 | $296K | Buy |
8,312
+2,285
| +38% | +$81.3K | 0.02% | 676 |
|
|
2022
Q4 | $212K | Buy |
+6,027
| New | +$212K | 0.02% | 654 |
|
|
2022
Q2 | – | Sell |
-3,807
| Closed | -$207K | – | 671 |
|
|
2022
Q1 | $207K | Buy |
3,807
+18
| +0.5% | +$979 | 0.02% | 609 |
|
|
2021
Q4 | $209K | Buy |
+3,789
| New | +$209K | 0.02% | 608 |
|
|
2020
Q4 | – | Sell |
-5,186
| Closed | -$244K | – | 509 |
|
|
2020
Q3 | $244K | Buy |
5,186
+96
| +2% | +$4.52K | 0.06% | 373 |
|
|
2020
Q2 | $260K | Sell |
5,090
-57
| -1% | -$2.91K | 0.07% | 357 |
|
|
2020
Q1 | $243K | Sell |
5,147
-239
| -4% | -$11.3K | 0.08% | 319 |
|
|
2019
Q4 | $316K | Buy |
5,386
+58
| +1% | +$3.4K | 0.08% | 312 |
|
|
2019
Q3 | $284K | Buy |
5,328
+364
| +7% | +$19.4K | 0.08% | 317 |
|
|
2019
Q2 | $248K | Buy |
4,964
+584
| +13% | +$29.2K | 0.08% | 326 |
|
|
2019
Q1 | $228K | Buy |
4,380
+2,326
| +113% | +$121K | 0.07% | 342 |
|
|
2018
Q4 | $98K | Buy |
+2,054
| New | +$98K | 0.04% | 463 |
|
|
2018
Q1 | $105K | Buy |
2,142
+1,391
| +185% | +$68.2K | 0.05% | 426 |
|
|
2017
Q4 | $33K | Buy |
+751
| New | +$33K | 0.02% | 726 |
|